Mark Ahlman

Associate Professor

Mark Ahlman

Associate Professor

Academic Appointment(s)

Medical College of Georgia
Department of Radiology and Imaging

Bio

Dr. Ahlman is a medical graduate of the Medical College of Georgia, with further training as a resident at the Medical University of South Carolina, and as a research fellow at the National Institutes of Health. He comes back to MCG as faculty in 2023 after his nuclear medicine practice at the NIH. He is trained in the design and conduct of clinical trials that utilize radiological endpoints to monitor disease.

Education

  • MD, Medicine Augusta University, 2008

  • BS, Biology/Biological Sciences, G Columbus State University, 2004

Certifications

  • PHY GA Professional Licensing BRD, 2022

Awards & Honors

  • Distinguished Peer Reviewer Journal Radiology (Annual) , 2022

  • RSNA Award 2019

  • Bedside Award NIH Bench, 2018

  • PMAP Employee Performance Awardee 2013

  • Competitive Position Imaging Sciences Training Program Imaging Sciences Training Program, 2012

Courses Taught Most Recent Academic Year

  • RRAD 5000

    Radiology Diagnostic

Teaching Interests

Nuclear Medicine, Large Vessel Vasculitis, Radiology

Scholarship

Selected Recent Publications

  • Longitudinal Characterization of Vascular Inflammation and Disease Activity in Takayasu Arteritis and Giant Cell Arteritis: A Single‐Center Prospective Study, 2023
    Journal Article, Professional Journal
  • Micronutrient Supplementation and Bone Health After Prophylactic Total Gastrectomy in Patients With CDH1 Variants, 2023
    Journal Article, Professional Journal
  • Transient responses and significant toxicities of anti-CD30 CAR T cells for CD30+ lymphomas: results of a phase I trial, 2023
    Journal Article, Academic Journal
  • “Association of 18F‐Fluorodeoxyglucose–Positron Emission Tomography Activity With Angiographic Progression of Disease in Large Vessel Vasculitis.”, 2023
    Journal Article, Academic Journal
  • Advances in PET Imaging of the CXCR4 Receptor:[68Ga] Ga-PentixaFor, 2023
    Journal Article, Professional Journal